VolitionRX Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
VNRX American 8731 https://volition.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for VolitionRX Ltd

VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock - Jun 5th, 2023 8:10 pm
VolitionRx Limited Announces Pricing of $16.5 Million Underwritten Public Offering of Common Stock - Jun 1st, 2023 1:15 pm
VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock - May 31st, 2023 8:01 pm
Volition Study shows Nucleosome Concentrations are a useful tool for Canine Cancer Treatment Monitoring - May 11th, 2023 11:00 am
VolitionRx Limited Announces First Quarter 2023 Financial Results and Business Update - May 10th, 2023 8:10 pm
VolitionRx Limited Schedules First Quarter 2023 Earnings Conference Call and Business Update - May 5th, 2023 12:00 pm
VolitionRx Limited to Host Capital Markets Day at the NYSE on Thursday May 11. - Apr 26th, 2023 11:30 am
Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV - Apr 24th, 2023 1:00 pm
VolitionRx Limited Announces Full Fiscal Year 2022 Financial Results and Business Update - Mar 15th, 2023 8:10 pm
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing - Mar 10th, 2023 1:35 pm
VolitionRx Limited Schedules Full Year 2022 Earnings Conference Call and Business Update - Mar 10th, 2023 1:00 pm
Life Sciences Virtual Investor Forum Agenda Announced for March 9th - Mar 7th, 2023 1:35 pm
VolitionRx Limited to Webcast Live at VirtualInvestorConferences.com March 9th - Mar 6th, 2023 9:30 pm
VNRX: Nu.Q Vet Cancer Test Being Launched by Supply Agreement Partners Heska and IDEXX; 4.945 million Share Offering Completed to Help Fund Management’s Initiatives - Feb 27th, 2023 9:42 am
VolitionRx Limited Announces Closing of $8.7 Million Underwritten Public Offering of Common Stock - Feb 22nd, 2023 9:10 pm
VolitionRx Limited Announces Pricing of $7.525 Million Underwritten Public Offering of Common Stock - Feb 17th, 2023 1:30 pm
Volition's Nu.Q® Vet Cancer Test Now Available for Pre-Order at The Point-of-Care Through Heska Corporation - Feb 16th, 2023 1:00 pm
Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on January 25, 2023 - Jan 23rd, 2023 1:00 pm
Volition to Take Part in Nu.Q® Vet Commercial Strategy Webinar - Jan 20th, 2023 1:30 pm
Sidoti's January Micro-Cap Conference - Jan 17th, 2023 3:00 pm